Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
The Crypto Company
Edit Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
My Portfolio
(CSE:
NARA
)
0.1800
UNCHANGED
Delayed Quote
Updated: 9:30 AM EST, Nov 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about NARA
PanGenomic Health Announces Exclusive Distributorship Agreement with Colombian Subsidiary of Ayla Bioscience and Expiration of Non-Binding Letter of Intent
November 19, 2026
Vancouver, British Columbia, Canada, November 19, 2026 – TheNewswire - PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA, FSE:LL3) announces that it is has signed an exclusive...
Via
TheNewswire.com
How Technology Can Be a Game Changer in Mental Health Treatment and AI Is Leading the Way
November 22, 2023
Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - November 22, 2023) - Investorideas.com (www.investorideas.com), a global investor news source covering...
Via
Newsfile
Topics
Artificial Intelligence
Mydecine Innovations Group Closes Sale of Its Wholly-Owned Subsidiary, Mindleap Health Inc.
December 12, 2022
From
Mydecine Innovations Group Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.